Efficacy and safety of erythrocytapheresis and low‐dose erythropoietin for treatment of hemochromatosis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21477
Abstract: The aim of this study was to determine retrospectively the efficacy of combined therapy using erythropoietin (EPO) and erythrocytapheresis (EA) in patients with hereditary hemochromatosis (HH) who did not tolerate phlebotomy. read more here.
Keywords: efficacy safety; hemochromatosis; efficacy; erythrocytapheresis low ... See more keywords